Jeffrey Halford, DO
Physical Medicine & Rehabilitation · Tulsa, OKNPI 1265454722
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $290 and has fallen 77.9% since, to $64 in 2025. Among physical medicine & rehabilitation clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $23.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Averitas Pharma Inc.$151
- GRT US Holding, Inc.$139
- Merz North America, Inc.$139
- Collegium Pharmaceutical, Inc.$131
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$75
- Scilex Pharmaceuticals Inc.$64
- plus $226 from 9 others
What the payments were for
- Food & beverage$925100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Averitas Pharma Inc. | 6 | $151 |
| GRT US Holding, Inc. | 2 | $139 |
| Merz North America, Inc. | 1 | $139 |
| Collegium Pharmaceutical, Inc. | 8 | $131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $75 |
| Scilex Pharmaceuticals Inc. | 3 | $64 |
| Medtronic(2 entities) | 3 | $45 |
| Sentynl Therapeutics, Inc. | 3 | $43 |
| Pfizer | 2 | $29 |
| Appliedvr Inc | 1 | $27 |
| Biodelivery Sciences International, Inc. | 2 | $23 |
| Valinor Pharma, LLC | 1 | $21 |
| Nevro Corp. | 1 | $15 |
| Medline Industries LP | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$925 in reported general payments places this provider in the 90th percentile of 51 physical medicine & rehabilitation providers in Oklahoma.
See all physical medicine & rehabilitation providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,668 | $93,559 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,570 | $49,343 |
| Xtampza ErOxycodone Myristate | 55 | $23,246 |
| OxycontinOxycodone Hcl | 58 | $20,497 |
| BelbucaBuprenorphine Hcl | 18 | $15,051 |
| Oxycodone Hcl | 676 | $10,346 |
| Morphine Sulfate ErMorphine Sulfate | 336 | $7,353 |
| Buprenorphine | 32 | $6,293 |
| Morphine Sulfate | 187 | $5,375 |
| Naloxone Hcl | 79 | $4,946 |
| Hydromorphone Hcl | 291 | $4,715 |
| Hysingla ErHydrocodone Bitartrate | 13 | $4,314 |
| Pregabalin | 51 | $1,672 |
| Fentanyl | 17 | $1,543 |
| Buprenorphine Hcl | 37 | $1,426 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $131 | $38,29873 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 51 physical medicine & rehabilitation providers in Oklahoma.
Other physical medicine & rehabilitation in Tulsa
- Isaiah WilsonTulsa$41K
- Aaron McGuireTulsa$428
- Perri CravenTulsa$210
- Valerie SantiagoTulsa$147
- Kara WrightTulsa$139
- Jenny SmithTulsa$121
- Brandon GreenTulsa$40
- Kristin BristowTulsa$23
- Andrew BriggemanTulsa$15
- Jodi YelvertonTulsa$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.